Jacob Van Naarden Eli Lilly & CO (LLY) insider trading activity
Jacob Van Naarden is EVP & Pres., Lilly Oncology of ELI LILLY & Co. Currently has a direct ownership of 13,458 shares of LLY, which is worth approximately $11.1 Million. The most recent transaction as insider was on Feb 01, 2025, when has been sold 1,409 shares (Common Stock) at a price of $811.08 per share, resulting in proceeds of $1,142,811. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.5K
13.62%
3M change
2.32%
12M change
Total Value Held
$11.1 Million
Jacob Van Naarden Transaction History
JVN
Jacob Van Naarden
EVP & Pres., Lilly Oncology
Indianapolis, IN